Uterine Fibroids Treatment Drugs Market
According to Intent Market Research, the Uterine Fibroids Treatment Drugs Market is expected to grow from USD 1.7 billion in 2024-e at a CAGR of 8.3 % to touch USD 3.0 billion by 2030. The Uterine Fibroids Treatment Drugs Market is dominated by key players such as AbbVie Inc., Bayer AG, Merck & Co., Inc. and Pfizer Inc.